CP
Cipher Pharma
CPH.TO·TSXMississauga CAFounded 200020 employees
Micro CappharmaPublicDermatologyGI
Platform: Branded Generic
Market Cap
$0.05B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (CPH.TO)
Loading CPH.TO stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rilulemzoparlimab | CPH-9367 | Approved | 2 | KIF18A | Cholangiocarcinoma | ||
| Fixatinib | CPH-8833 | Phase 1/2 | 2 | IL-17A | OCDMigraine |
SEC Filings & Financial Documents
SEC filings are not available for TSX-listed companies.
Cipher Pharma trades on TSX (CA). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)